abstract |
The present invention relates to a binding molecule having neutralizing activity in the coronavirus superfamily. More specifically, the binding molecule of the present invention is a SARS-coronavirus-2 (SARS-CoV-2) wild-type and mutated virus that may occur in the future, as well as SARS-coronavirus (SARS-) that infects humans and causes fatal diseases. CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), etc. have excellent binding ability to various types of coronaviruses that are likely to infect humans, and exhibit excellent neutralizing effect. Very useful for diagnosis, prevention or treatment. |